About Us
Our Vision
ScienceToLife provides enhanced learning through engaging, virtual experiences.
What We Do
We provide Life Science organisations with a secure and seamless digital medical education, including footprint optimisation.
Sandra Owens – CEO
Let me introduce myself! I have worked in both education and the Life Sciences sector for over 20 years in large global pharmaceutical organisations as well as medium sized biotechs across the Asia Pacific Region. From several Business Unit Director positions to CEO of AccessOncology, an organisation managing Oncology clinical trials, I have loved working in this fast paced and evidence driven industry that is delivering patient benefit every, single day of the year.
It is clear to me that Life Sciences is one of the most exciting areas to work within, since it is this group that brings new medicines to patients, whether it be in early phase clinical trials or delivering new data to HCPs that is creating better and more life for patients.
The opportunity to encourage and help more candidates into the Life Sciences sector has always been a passion and I have mentored hundreds of people through my career to date. My experience has taken me across many organisations - Sanofi, Merck, Johnson & Johnson and AstraZeneca.
Virtual medical education was a natural extension of our online learning platform and has kept us busy during the COVID-19 pandemic now that organisations are interested in launching virtual symposia in tandem with National and International meetings.
Email us at [email protected] if you have any questions.
Rose Brown – COO
Rose has experience in, and passion for, developing virtual tools to enhance medical education and engagement.
Rose has over 20 years experience in Life Science companies including Eli Lilly & Sanofi and in fact worked as one of the first medico marketing managers in the industry. She works with a solution focused attitude to overcome key challenges and drive business results with quality outcomes.
Rose has a proven track record in driving new product and clinical program development from Phase I to Phase IV. She has substantial market understanding & financial analysis skills which has resulted in successful product launches in Oncology, Haematology & Neurology.
Her public health experience and established relationships with key influencers in Australia & New Zealand has been critical in market analysis and performance delivery.
Email us at [email protected] if you have any questions.
